Health Section 7.1.34

Laboratory Report #34

Date

Collection Date: November 12, 2024
Report Date: November 16, 2024

Laboratory

Labcorp

Ordering Physician

Dr. Billy R. Boring, Jr.

Report Type

Comprehensive Annual Health Evaluation

Laboratory testing included:

Complete Blood Count (CBC) with Differential
Comprehensive Metabolic Panel (CMP)
Routine Urinalysis
Lipid Panel
Vitamin B12 and Folate
Hemoglobin A1c
Free T4
TSH
Cortisol
Magnesium
Zinc
C-Reactive Protein (CRP)

Original Report

PDF: Labcorp – November 12, 2024

Purpose of Testing

This comprehensive annual laboratory evaluation was performed approximately ten months after beginning your strict carnivore diet. The goals were to monitor recovery of the persistent anemia, assess inflammatory activity, evaluate kidney and liver function, review thyroid replacement therapy, monitor cardiovascular risk factors, and measure long-term metabolic health.

This report is one of the strongest in your Health Inventory because it documents continued excellent inflammatory control, significant improvement in the anemia, preserved kidney function, and an exceptionally favorable HDL/triglyceride profile, while identifying LDL cholesterol and Hemoglobin A1c as the principal ongoing areas for discussion.

Major Findings

1. Complete Blood Count (CBC)

Results

Test	Result	Interpretation
WBC	4.7 ×10³/µL	Normal
RBC	4.15 ×10⁶/µL	Normal (low end)
Hemoglobin	12.6 g/dL	Slightly Low
Hematocrit	39.3%	Normal
Platelets	208 ×10³/µL	Normal

Interpretation

This report demonstrates substantial recovery from the anemia documented earlier in 2024.

Hemoglobin Trend

Date	Hemoglobin
November 2023	13.1
June 2024	11.2
August 2024	11.3
November 2024	12.6

The historical graph on page 5 clearly shows this upward trend. Although hemoglobin remained just below the laboratory reference range, the improvement from 11.2 to 12.6 g/dL over five months represents meaningful hematologic recovery.

2. White Blood Cell Differential

Results

Neutrophils: 52%
Lymphocytes: 29%
Monocytes: 11%
Eosinophils: 8%
Absolute Eosinophils: 0.4 ×10³/µL (Upper limit of normal)

Interpretation

One of the most encouraging findings is the improvement in eosinophilia.

Compared with June 2024:

Eosinophils: 19% → 8%
Absolute eosinophils: 0.9 → 0.4 ×10³/µL

The previously elevated eosinophil count has essentially normalized, reducing concern for ongoing allergic or inflammatory activation.

3. Kidney Function

Results

BUN: 33 mg/dL (High)
Creatinine: 0.88 mg/dL
eGFR: 83 mL/min/1.73 m²
BUN/Creatinine Ratio: 38 (High)

Interpretation

Kidney filtration remains excellent.

Compared with June 2024:

Creatinine improved slightly (0.92 → 0.88).
eGFR improved (81 → 83).
BUN decreased (40 → 33), although it remains above the laboratory reference range.

Given your high-protein carnivore diet, the persistently elevated BUN and BUN/Creatinine ratio are likely influenced by dietary protein intake and hydration status rather than impaired kidney function.

4. Liver Function

Results

AST: 31 IU/L
ALT: 27 IU/L
Alkaline Phosphatase: 59 IU/L
Bilirubin: 0.3 mg/dL

Interpretation

Liver function remains completely normal.

5. Lipid Panel

Results

Test	Result
Total Cholesterol	243 mg/dL (High)
LDL Cholesterol	141 mg/dL (High)
HDL Cholesterol	94 mg/dL
Triglycerides	52 mg/dL

Interpretation

The lipid profile continues to show a distinctive pattern.

Positive Findings

HDL increased dramatically to 94 mg/dL, the highest value recorded.
Triglycerides remained exceptionally low (52 mg/dL).

Ongoing Discussion Point

LDL increased slightly (136 → 141 mg/dL) but remained below the 151 mg/dL values seen in late 2022 and 2023.

The cardiovascular summary on page 7 provides an excellent visual comparison of lipid values from January 2022 through November 2024.

6. Metabolic Health

Results

Fasting Glucose: 87 mg/dL
Hemoglobin A1c: 5.8% (High)

Interpretation

Fasting glucose remained excellent.

However, Hemoglobin A1c increased from 5.4% (August 2024) to 5.8%, returning to the laboratory’s prediabetes range.

The historical chart on page 6 illustrates this fluctuation. Because your fasting glucose remained normal and you have experienced intermittent anemia, this A1c value should be interpreted within the broader clinical context rather than in isolation.

7. Thyroid Function

Results

Free T4: 1.24 ng/dL
TSH: 1.110 μIU/mL

Interpretation

Thyroid replacement therapy continues to provide excellent control.

Both values remain comfortably within the normal reference ranges.

8. Inflammatory Status

C-Reactive Protein (CRP)

Result

1 mg/L

Reference Range:

0–10 mg/L

Interpretation

This is one of the strongest findings in the report.

Historical progression:

Date	CRP
October 2021	32 mg/L
July 2022	6 mg/L
June 2024	2 mg/L
November 2024	1 mg/L

The continued decline in CRP demonstrates excellent long-term inflammatory control.

9. Nutritional Status

Results

Vitamin B12: 1,062 pg/mL
Folate: 9.7 ng/mL
Magnesium: 2.2 mg/dL
Zinc: 121 µg/dL (Slightly High)

Interpretation

Overall nutritional status remains excellent.

The mildly elevated zinc level most likely reflects supplementation and is not generally concerning in isolation.

10. Urinalysis

Findings

Normal:

Clear urine
No protein
No glucose
No blood
No ketones
No infection markers

Microscopic examination was not indicated.

Interpretation

Urinalysis remained entirely normal, providing no evidence of kidney disease or urinary tract pathology.

Overall Interpretation

This report demonstrates continued improvement in overall health.

Major Positive Findings

✅ Hemoglobin improved substantially.
✅ Hematocrit returned to normal.
✅ Eosinophilia resolved.
✅ CRP decreased further to 1 mg/L.
✅ Kidney filtration remained excellent.
✅ HDL reached an exceptional 94 mg/dL.
✅ Triglycerides remained extremely low.
✅ Liver and thyroid function remained normal.

Areas for Continued Monitoring

⚠ Mild residual anemia (improving).
⚠ Persistently elevated LDL cholesterol.
⚠ Elevated BUN likely related to diet and hydration.
⚠ Hemoglobin A1c increased to 5.8% despite normal fasting glucose.

Longitudinal Significance

This report contributes to:

CBC Trend Table
Hemoglobin Trend Table
CRP Trend Table
Kidney Function Trend Table
Lipid Trend Table
Hemoglobin A1c Trend Table
Thyroid Trend Table
Lifestyle & Diet Impact Timeline
Medical History Timeline

Clinical Importance

⭐⭐⭐⭐⭐ Major Recovery and Stability Report

This report is among the strongest in your entire Laboratory Library because it demonstrates measurable improvement across several systems while confirming that the severe inflammatory illness of 2021 has remained in remission.

Key Findings

Hemoglobin: 12.6 g/dL (Improved)
Hematocrit: *39.3% (Normal)
CRP: 1 mg/L
LDL: 141 mg/dL
HDL: 94 mg/dL
Triglycerides: 52 mg/dL
Creatinine: 0.88 mg/dL
eGFR: 83
Hemoglobin A1c: 5.8%
Eosinophils normalized from 19% → 8%

Related Reports

August 12, 2024 – CBC Follow-up Evaluation
June 26, 2024 – Comprehensive Health Evaluation
November 13, 2023 – Annual Health Evaluation
Cardiovascular Trend Table
Inflammatory Marker Trend Table
CBC Trend Table
Lifestyle & Diet Impact Timeline

Navigation

Previous Report: August 12, 2024 – CBC Follow-up Evaluation
Next Report: 2025 Comprehensive Laboratory Evaluation
Return to Laboratory Library
Return to Health Inventory

Observation

This report marks another important milestone in your Health Inventory. Looking at the historical graphs on pages 5–7, three long-term trends stand out:

Inflammation has steadily improved, with CRP falling from a peak of 32 mg/L in 2021 to 1 mg/L.
The anemia is recovering, with hemoglobin rising from 11.2 g/dL in June 2024 to 12.6 g/dL.
Your cardiovascular profile remains unusual but consistent—very high HDL, very low triglycerides, and moderately elevated LDL. This distinctive pattern is worth continuing to discuss with your cardiologist in the context of your overall cardiovascular risk profile rather than focusing on LDL alone.

Of all the laboratory reports from 2024, this is probably the strongest summary of your overall health status and provides an excellent transition into your 2025 laboratory evaluations.